RecruitingNCT05121012

Synaptic Loss in Multiple System Atrophy

Molecular Imaging of Synaptic Loss in Multiple System Atrophy (MSA)


Sponsor

University of Exeter

Enrollment

36 participants

Start Date

Sep 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

In this study the investigators would like to investigate the degree of damage of the synapses, an important part of the neurons vital for the communications between neurons, in Multiple System Atrophy (MSA), and pathology related to abnormal accumulation of a protein named tau, in Progressive Supranuclear Palsy (PSP).


Eligibility

Min Age: 45 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is using a specialized brain PET scan to look at synapse (nerve connection) loss in people with multiple system atrophy (MSA) — a rare and progressive neurological disorder that affects movement, balance, and automatic body functions. Understanding where and how quickly synapses are lost may help researchers track disease progression and test future treatments. **You may be eligible if...** - You are 45–80 years old with a diagnosis of probable or possible MSA (based on established clinical criteria) - You are able to complete brain scanning and study procedures - If female, you are post-menopausal, surgically sterile, or using adequate contraception - You have a healthy volunteer available to act as a comparison group participant (healthy volunteers are also enrolled in separate cohorts) **You may NOT be eligible if...** - You have significant other neurological or psychiatric conditions that might interfere - You have active cancer or are receiving chemotherapy or other treatments that could affect brain imaging - You are pregnant or breastfeeding - You are claustrophobic or otherwise unable to undergo PET/MRI scanning - You have significant kidney or liver impairment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERStudy procedures for MSA patients

The group of MSA patients will undergo a collection of demographic data, a neurological examination with administration of clinical scales relevant for MSA, and a collection of venous blood sample for routine and biomarker analyses. Participants will undergo one PET scan with the tracer \[11C\]UCB-J, and one PET scan with the tracer \[18F\]FDG. All participants will also undergo one MRI scan. Participants will also undergo one lumbar puncture (optional). All procedures will be performed at baseline and after one-year follow-up. A subgroup of patients with MSA will also undergo, at one time point only, one PET scan with the tracer \[18F\]APN107.

OTHERStudy procedures for PSP patients

The group of PSP patients will undergo a collection of demographic data, a neurological examination with administration of clinical scales relevant for PSP, and a collection of venous blood sample for routine and biomarker analyses. Participants will undergo one PET scan with the tracer \[18F\]APN107 and one MRI scan. All procedures will be performed at baseline and after one-year follow-up.


Locations(1)

University of Exeter

Exeter, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05121012


Related Trials